[mpc_image image=”9200″ image_size=”full” force_fullwidth=”true” image_opacity=”100″ image_inner_border_gap=”0″ effect=”none” image_hover_opacity=”100″]


Meprobamate is a drug marketed as a sedative, anxiolytic agent or muscle relaxant that has major potential for abuse and dependency, especially when combined with alcohol or other central nervous system depressants. In cases of overdose, meprobamate produces CNS depression and neurological symptoms including lethargy, stupor, slurred speech, headache, weakness and prolonged coma in extreme overdoses. In the United States, meprobamate is listed as a Schedule IV drug in the Controlled Substances Act. However, meprobamate’s parent drug carisoprodol, which is widely prescribed for musculoskeletal conditions, is not subject to federal control even though it has the potential for abuse.

Product Number: MPB10020

Cross Reactivity

AnalyteLODMatricesCompoundsCross Reactivity %
Meprobamate7.64 ng/mLWhole Blood, Post Mortem Blood, UrineMeprobamate100
*LOD is standardised to this compound

Request Demo